דמוסטין 25 מ"ג - Demustin 25 mg

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.